The essential role of the in situ immune reaction in human colorectal cancer
/in Colorectal Cancer, International Publications /von 2008-06-17 / J. Leukoc. Biol. 2008 Oct;84(4):981-7Dendritic cell therapy in combination with interferon-alpha for the treatment of metastatic renal cell carcinoma
/in Dendritic Cells, Hypernephroma, International Publications /von 2008-06-16 / Int. J. Urol. 2008 Aug;15(8):694-8Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors
/in International Publications, Newcastle Disease Virus, NSCLC /von 2008-06-06 / Cancer Gene Ther. 2008 Dec;15(12):795-807Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2008-06-05 / Virus Res. 2008 Sep;136(1-2):75-80Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer
/in Colorectal Cancer, International Publications, IOZK Veröffentlichungen /von 2008-06-03 / Ann. Surg. Oncol. 2008 Aug;15(8):2310-7Immunotherapy of pancreatic carcinoma
/in International Publications, Pancreatic Cancer /von 2008-06-01 / Curr Opin Investig Drugs 2008 Jun;9(6):565-9Melanoma and lymphoma rejection associated with eosinophil infiltration upon intratumoral injection of dendritic and NK/LAK cells
/in International Publications, Malignant Melanoma /von 2008-06-01 / J. Immunother. 2008 Jun;31(5):458-65[Immunotherapy for glioma]
/in Glioblastoma, International Publications /von 2008-06-01 / Gan To Kagaku Ryoho 2008 Jun;35(6):926-30IFN-gamma down-regulates Hsp27 and enhances hyperthermia-induced tumor cell death in vitro and tumor suppression in vivo
/in International Publications, NSCLC /von 2008-06-01 / Int. J. Oncol. 2008 Jun;32(6):1317-24
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution